Introduction: Patients with schizophrenia require medication that is taken regularly for long periods of time. Non-adherence to antipsychotics is considered the main reason for hospital readmission. Objectives: To assess the prevalence of non-adherence in schizophrenic patients under antipsychotic treatment and to identify socio-demographic and clinical factors that might influence adherence to treatment. Methods: This prospective study was conducted in several psychiatric private practices located in Timișoara, between October 2014 and October 2016 and included 60 patients diagnosed with paranoid schizophrenia according to ICD-10 criteria, that were followed-up for six months. Clinical interviews, the BPRS – Brief Psychiatric Rating Scale (used to assess symptom severity) and a shorter version of the ROMI – Rating of Medical Influences scale (used to rate patient attitudes toward adherence) were applied at baseline. The BPRS was also used in the follow-up visits (once a month). We divided the patients into two samples considering treatment adherence and we compared data. Results: For the whole sample, the mean disorder duration was 12.6 ± 7.6 years and the mean number of hospitalizations was 6.4 ± 4.5. Younger patients were more adherent to treatment than elderly patients, whilst single patients or those living alone were more frequently non-adherent. We obtained statistically significant differences between the study groups (adherent vs. non-adherent) regarding disorder duration (p=0.04) and mean number of hospitalizations (p=0.02). The main two reasons for non-adherence to pharmacotherapy were discomfort caused by the medication's adverse effects (37.5%), and the fact that medication is not currently needed – from the patient's standpoint (21.8%). The most important reasons for adherence to pharmacotherapy were: the perceived daily benefit brought on by antipsychotic medication (32.1%) and relapse prevention (17.9%). Conclusions: Age, marital status, and disorder duration are factors with the most important influence on treatment adherence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.